1. A review on the importance of LINC-ROR in human disorders
   Soudeh Ghafouri-Fard et al, 2023, Pathology - Research and Practice CrossRef
2. GK921, a transglutaminase inhibitor, strengthens the antitumor effect of cisplatin on pancreatic cancer cells by inhibiting epithelial-to-mesenchymal transition
   Mengxin Li et al, 2024, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
3. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
   Giasemi C. Eptaminitaki et al, 2022, Drug Resistance Updates CrossRef
4. Decoding hepatocarcinogenesis from a noncoding RNAs perspective
   Mostafa K. Abd El‐Aziz et al, 2023, Journal of Cellular Physiology CrossRef
5. Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer
   Hai-Bo Zhang et al, 2023, Frontiers in Pharmacology CrossRef
6. Functional Relevance of the Long Intergenic Non-Coding RNA Regulator of Reprogramming (Linc-ROR) in Cancer Proliferation, Metastasis, and Drug Resistance
   José A. Peña-Flores et al, 2023, Non-Coding RNA CrossRef
7. Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients
   Shenglan Huang et al, 2022, Frontiers in Medicine CrossRef
8. Linc-ROR drive adriamycin resistance by targeting AP-2α/Wnt/β-catenin axis in hepatocellular carcinoma
   Chuan-Jian Shi et al, 2023, Cell Biology and Toxicology CrossRef
9. Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer
   Po-Shuan Huang et al, 2023, Cells CrossRef
10. Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma
    Qikuan He et al, 2022, Cancer Cell International CrossRef
11. The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma
    Alina-Veronica Ghionescu et al, 2023, Frontiers in Pharmacology CrossRef
12. α-Mangostin Inhibits the Activation of Myofibroblasts via Downregulation of Linc-ROR-Mediated TGFB1/Smad Signaling
    Yu-Hsien Lee et al, 2023, Nutrients CrossRef
13. Resistance of Lenvatinib in Hepatocellular Carcinoma
    Qiuran Xu et al, 2022, Current Cancer Drug Targets CrossRef
14. Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular targets for precision interventions
    Min Zheng et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
15. Role of Long Non-Coding RNA Polymorphisms in Cancer Chemotherapeutic Response
    Zheng Zhang et al, 2021, Journal of Personalized Medicine CrossRef
16. Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association
    Nada M. El-Sheikh et al, 2022, Pathology - Research and Practice CrossRef